EWA
GWPH

Evolution Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Evolution Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-203
Closed -$23K – 676
2020
Q4 		$23K Sell
203
-27
-12% -$3.02K 0.01% 249
2020
Q3 		$22K Buy
230
+23
+11% +$2.65K 0.01% 263
2020
Q2 		$25K Hold
207
– – 0.01% 192
2020
Q1 		$18K Buy
207
+17
+9% +$1.8K 0.01% 159
2019
Q4 		$20K Buy
190
+117
+160% +$13.1K 0.01% 228
2019
Q3 		$8K Buy
+73
New +$11.1K ﹤0.01% 222

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Evolution Wealth Advisors's GWPH Position: Q1 2021 in Review

Evolution Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 203 shares — an estimated $23K sold.

Evolution Wealth Advisors first reported a position in GWPH in Q3 2019 and held it in 6 quarters. The position peaked at $25K in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Evolution Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 203 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $23K.
  • Evolution Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 6 quarters.
  • Evolution Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $25K in Q2 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Evolution Wealth Advisors's 13F filing for Q1 2021, filed 20 Apr 2021.